Evidence map›Paper›PMID 40420845›Full record

ArticleCase reports in pediatrics2025

Clinical and Morphological Bone Marrow Characteristics of Pearson Syndrome: About Three Consecutive Cases and Review of the Literature.

Gaetan-Nagim Degroot, Aurélie Empain, Laurence Dedeken, Anne Demulder, Laurence Rozen

Abstract readCase Reports
In one paragraph

Article in Case reports in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gaetan-Nagim DegrootLaboratory of Hematology, Brussels University Hospital Laboratory (LHUB), Université Libre de Bruxelles (ULB), Brussels, Belgium.ORCID https://orcid.org/0009-0005-5270-1161
Aurélie EmpainDepartment of Paediatrics, Metabolic and Nutrition Unit, Division of Endocrinology, Diabetes and Metabolism, Queen Fabiola Children's University Hospital (HUDERF)-H.U.B., Metabolic Centre ULB-VUB, Brussels, Belgium.ORCID https://orcid.org/0000-0002-2641-0150
Laurence DedekenDepartment of Paediatrics, Hematology-Oncology Department, Queen Fabiola Children's University Hospital (HUDERF)-H.U.B., Université Libre de Bruxelles (ULB), Brussels, Belgium.ORCID https://orcid.org/0000-0001-7829-6428
Anne DemulderLaboratory of Hematology, CHU Brugmann University Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium.ORCID https://orcid.org/0000-0002-5272-8939
Laurence RozenLaboratory of Hematology, CHU Brugmann University Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium.ORCID https://orcid.org/0000-0003-4345-7409

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pearson syndrome (PS) is a rare and fatal multisystem disorder caused by a mitochondrial DNA (mtDNA) deletion. Most patients develop refractory anemia in early infancy, rapidly followed by multiple complications such as failure to thrive, muscle hypotonia, pancreatic insufficiency, and renal tubulopathy. Although the definitive diagnosis is established by mtDNA sequencing, bone marrow (BM) cytology is a cornerstone of diagnosis, typically revealing precursor vacuolization and ring sideroblasts. We report here three cases of patients with PS encountered in our institution and summarize the clinical and hematological features of PS through a systematic review of the literature. The first symptoms mostly appear during the first month of life and rarely after 18 months. Hyporegenerative anemia, a hallmark of the disease, is the most common initial symptom, followed at a distance by neutropenia and thrombocytopenia. Gastrointestinal and metabolic symptoms such as failure to thrive and lactic acidosis are the most frequent non-hematological symptoms, even in the rare cases without hyporegenerative anemia. Vacuolization of BM precursors, observed in the vast majority of PS patient BMAs, is not influenced by the patient's age at sampling. Ring sideroblasts, the other feature of PS BMAs, are less frequent than progenitor vacuolization but increase significantly after 6 months of age. These abnormalities are just as common in patients with or without hematological symptoms, suggesting that BMA should be performed in all suspected PS cases, despite the absence of anemia. PS is a multisystem disorder requiring early diagnosis and a coordinate multidisciplinary management, involving clinicians and clinical biologists.

Indexed as

bone marrow characteristicsclinical featureshyporegenerative anemiamitochondrial DNA deletionPearson's syndrome

Identifiers

PMID40420845
PMCPMC12103953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.